Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration
Clinical trial NCT04864834 · COMPLETED
Trial details
- NCT number
- NCT04864834
- Sponsor
- Sandoz
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-12
- Primary completion
- 2022-07-07
- Enrollment
- 485
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.